Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Cost of Revenue (2016 - 2026)

Myriad Genetics has reported Cost of Revenue over the past 17 years, most recently at $35.8 million for Q4 2025.

  • Quarterly Cost of Revenue fell 60.92% to $35.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $237.3 million through Dec 2025, down 18.31% year-over-year, with the annual reading at $247.9 million for FY2025, 12.74% down from the prior year.
  • Cost of Revenue was $35.8 million for Q4 2025 at Myriad Genetics, down from $71.0 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $118.7 million in Q4 2022 and troughed at $5.7 million in Q2 2021.
  • The 5-year median for Cost of Revenue is $59.2 million (2023), against an average of $57.4 million.
  • Year-over-year, Cost of Revenue surged 771.93% in 2022 and then plummeted 60.92% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $47.8 million in 2021, then surged by 148.33% to $118.7 million in 2022, then crashed by 48.1% to $61.6 million in 2023, then soared by 48.7% to $91.6 million in 2024, then tumbled by 60.92% to $35.8 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Cost of Revenue are $35.8 million (Q4 2025), $71.0 million (Q3 2025), and $61.3 million (Q2 2025).